AKT1 and diabetic kidney disease: Additionally, FGF-1 has shown efficacy in preventing diabetic nephropathy by mitigating renal inflammation with a reduction in nuclear factor κB and c-Jun N-terminal kinase signaling pathways [27] and via the PI3K/AKT pathway in different studies [28].